中国癌症防治杂志
中國癌癥防治雜誌
중국암증방치잡지
CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
2014年
3期
235-242,243
,共9页
黄新飞%凌永赤%齐鲁楠%欧超
黃新飛%凌永赤%齊魯楠%歐超
황신비%릉영적%제로남%구초
肝肿瘤%黄曲霉毒素B1%蛋白质组学%iTRAQ技术
肝腫瘤%黃麯黴毒素B1%蛋白質組學%iTRAQ技術
간종류%황곡매독소B1%단백질조학%iTRAQ기술
Liver neoplasm%Aflatoxin B1%Roteomics%iTRAQ
目的:研究广西扶绥地区黄曲霉毒素B1(aflatoxin B1,AFB1)相关性肝细胞癌(hepatocellular carcinoma,HCC)的差异蛋白质表达谱,筛选与AFB1暴露相关的肝癌分子标志物,并初步探讨AFB1的致肝癌机制。方法40例HCC组织按照AFB1的暴露情况分为两个亚组:A组为AFB1暴露组(24例),B组为非AFB1暴露组(16例),同时收集10例来自肝血管瘤、肝外伤、肝移植供体等手术切除的正常肝组织作为正常对照。应用iTRAQ结合2DLC-MS/MS技术分析蛋白质表达谱在各组间的差异。结果按照组间差异参数ratio>2.0(上调)或ratio<0.5(下调)为筛选标准,两个亚组共鉴定出差异蛋白88种(上调的蛋白51种,下调的蛋白37种),其中50种差异蛋白在两个亚组中均有相同变化趋势,其余38种差异蛋白则存在AFB1暴露的病因学特异性。通过GO注释对筛选出的差异蛋白进行分类分析,88种差异蛋白主要定位于细胞质、细胞核及线粒体,以结合功能和催化功能相关蛋白为主,主要参与毒物代谢调节、应激反应及抗凋亡等生物学过程。结论本研究筛选出多种与AFB1暴露相关性HCC的差异蛋白,为探讨广西扶绥AFB1高暴露地区的HCC发病机制提供了新的线索。
目的:研究廣西扶綏地區黃麯黴毒素B1(aflatoxin B1,AFB1)相關性肝細胞癌(hepatocellular carcinoma,HCC)的差異蛋白質錶達譜,篩選與AFB1暴露相關的肝癌分子標誌物,併初步探討AFB1的緻肝癌機製。方法40例HCC組織按照AFB1的暴露情況分為兩箇亞組:A組為AFB1暴露組(24例),B組為非AFB1暴露組(16例),同時收集10例來自肝血管瘤、肝外傷、肝移植供體等手術切除的正常肝組織作為正常對照。應用iTRAQ結閤2DLC-MS/MS技術分析蛋白質錶達譜在各組間的差異。結果按照組間差異參數ratio>2.0(上調)或ratio<0.5(下調)為篩選標準,兩箇亞組共鑒定齣差異蛋白88種(上調的蛋白51種,下調的蛋白37種),其中50種差異蛋白在兩箇亞組中均有相同變化趨勢,其餘38種差異蛋白則存在AFB1暴露的病因學特異性。通過GO註釋對篩選齣的差異蛋白進行分類分析,88種差異蛋白主要定位于細胞質、細胞覈及線粒體,以結閤功能和催化功能相關蛋白為主,主要參與毒物代謝調節、應激反應及抗凋亡等生物學過程。結論本研究篩選齣多種與AFB1暴露相關性HCC的差異蛋白,為探討廣西扶綏AFB1高暴露地區的HCC髮病機製提供瞭新的線索。
목적:연구엄서부수지구황곡매독소B1(aflatoxin B1,AFB1)상관성간세포암(hepatocellular carcinoma,HCC)적차이단백질표체보,사선여AFB1폭로상관적간암분자표지물,병초보탐토AFB1적치간암궤제。방법40례HCC조직안조AFB1적폭로정황분위량개아조:A조위AFB1폭로조(24례),B조위비AFB1폭로조(16례),동시수집10례래자간혈관류、간외상、간이식공체등수술절제적정상간조직작위정상대조。응용iTRAQ결합2DLC-MS/MS기술분석단백질표체보재각조간적차이。결과안조조간차이삼수ratio>2.0(상조)혹ratio<0.5(하조)위사선표준,량개아조공감정출차이단백88충(상조적단백51충,하조적단백37충),기중50충차이단백재량개아조중균유상동변화추세,기여38충차이단백칙존재AFB1폭로적병인학특이성。통과GO주석대사선출적차이단백진행분류분석,88충차이단백주요정위우세포질、세포핵급선립체,이결합공능화최화공능상관단백위주,주요삼여독물대사조절、응격반응급항조망등생물학과정。결론본연구사선출다충여AFB1폭로상관성HCC적차이단백,위탐토엄서부수AFB1고폭로지구적HCC발병궤제제공료신적선색。
Objective To establish specific molecular marker profiles of aflatoxin B1 (AFB1)-related hepatocellular carcinoma (HCC)by comparing protein expression profiles between AFB1-related and non-AFB1-related HCC in the FuSui area of Guangxi. Method A total of 24 patients with AFB1-related HCC and 16 patients with non-AFB1-related HCC group were analyzed by isobaric tagging reagent(iTRAQ)quantitative proteomics together with 2DLC-MS/MS in order to identify differences in protein expression levels. In parallel,normal liver tissue from 10 patients who were liver donors,who had hepatic hemangioma or who had undergone liver resection was analyzed as a control. Results A total of 88 unique proteins were identified that were≥2-fold overexpressed(51 proteins) or≤0.5-fold underexpressed (37 proteins)in AFB1-related HCC tissue relative to control tissue.Of the 88 proteins,50 were expressed at similar levels in AFB1-related HCC and non-AFB1-related HCC tissue,while 38 were associated with pathological features.Based on gene ontology analysis,most of the 88 proteins are predicted to play roles as binding proteins and catalysts.Most are located in the cytoplasm,nucleus or mitochondria,and most are involved in detoxification,drug metabolism and anti-apoptotic pathways. Conclusions This study has identified several differentially expressed proteins associated with AFB1-related HCC in the FuSui area of Guangxi, which may provide clues to understanding AFB1-related hepatocarcinogenesis in this part of the world.